Clinical Trials Logo

Anemia, Iron Deficiency clinical trials

View clinical trials related to Anemia, Iron Deficiency.

Filter by:

NCT ID: NCT00741143 Completed - Clinical trials for Iron Deficiency Anemia

Effect of Iron Fortified Wheat Flour on Cognition and Iron Status in Indian School Children

Start date: August 2007
Phase: N/A
Study type: Interventional

This study is designed to evaluate the efficacy of NaFeEDTA-fortified whole wheat flour in improving cognition, hemoglobin, iron status and total body iron among school children in urban Bangalore.

NCT ID: NCT00740246 Completed - Anemia Clinical Trials

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and tolerability of VIT-45 in the treatment of Iron Deficiency Anemia

NCT ID: NCT00727545 Completed - Clinical trials for Iron Deficiency Anemia

Effect of Rice Fortification With Iron on Anemia Among Children

Start date: March 2006
Phase: Phase 2/Phase 3
Study type: Interventional

This was a double-blind community-based trial, placebo controlled. During 16 weeks, children in the intervention group (GI, n=180) received iron fortified rice, and children in the control group (GC, n=174) received rice with placebo. Anemia was considered present when hemoglobin < 11.0g/dL. Comparison of mean variation on hemoglobin between groups was accessed by using Student's t-test. Hemoglobin concentration improved in both groups, with mean increase of 0.42 g/dL in GI (11.28±1.23 g/dL to 11.75±1.16 g/dL, p < 0.001), and 0.49 g/dL in GC (11.06±1.13 g/dL to 11.51±1.16 g/dL, p < 0.001). Anemia decreased (p < 0.01) in both groups (37.8% to 23.3% in GI and 45.4% to 33.3% in GC), with no differences between them. Hemoglobin increase was significantly higher in children who received total amount of iron ≥ 53.76 mg from fortified rice, compared to those who received less than this cut-off value (0.94 g/dl vs 0.39 g/dl p=0.03). The results suggest that this type of intervention can be useful in anemia control if fortified food intake is adequate.

NCT ID: NCT00704353 Completed - Anemia Clinical Trials

Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia

Start date: June 2008
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent

NCT ID: NCT00704028 Completed - Anemia Clinical Trials

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

Start date: June 2008
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.

NCT ID: NCT00703937 Completed - Anemia Clinical Trials

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia

Start date: July 2008
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.

NCT ID: NCT00694954 Completed - Clinical trials for Iron Deficiency Anemia

Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding

Start date: February 2007
Phase: N/A
Study type: Interventional

The role of capsule endoscopy (CE) in patients with obscure / occult gastrointestinal (GI) bleeding remains unclear. This pragmatic randomized controlled trial is designed to determine the diagnostic yield and clinical outcomes of patients with obscure GI bleeding who receive CE compared to those who receive usual standard care.

NCT ID: NCT00689793 Completed - Fatigue Clinical Trials

Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors

ferdon
Start date: November 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the subjective response of iron substitution (Tardyferon®) on fatigue in women blood donors with a mean serum ferritin < 30ng/ml and to assess variation of ferritin and hemoglobin after a blood donation.

NCT ID: NCT00668694 Completed - Clinical trials for Iron Deficiency Anemia

Iron Deficiency Anemia and Psychosocial Stimulation

IDA
Start date: October 2007
Phase: N/A
Study type: Interventional

In developing countries, poor nutrition, high morbidity, poverty, poor parental education and stimulation in the home, all detrimentally affect children's development. These conditions frequently occur together increasing the risk of poor development. Iron deficiency anemia (IDA) affects large numbers of young children and is associated with poor child development. There is some question as to whether infants with IDA can catch up in mental development to non-IDA infants. We plan to examine the effect of psychosocial stimulation on IDA children's growth and development using a randomized controlled trial and compare them with non-anemic children. The study will be located in poor villages accessible to Dhaka. Villages will be randomized to either receive psychosocial stimulation or none. Children, aged 6-12 months, with IDA (hemoglobin (Hb) 80.0-109g/L, ferritin<12μg/L & Transferrin Recepter (TfR) >7) (n=212) or without anemia (Hb>109g/L, ferritin>12μg/L, C-reactive protein (CRP) <5 & TfR<7) (n=212) will be identified in those villages. Intervention will include weekly home visits for 9 months by a play leader, who will demonstrate play with home made toys and teach the mothers about child development. All IDA children will be given 30 mg ferrous-sulphate daily for 9 months. At the beginning and end of the study, the following measurements will be made: Bayley Scales of Infant Development (mental and motor indices), Wolke's behavior ratings, Hb, serum ferritin, CRP, Transferrin receptor, anthropometry, home stimulation, and mothers' knowledge and practices of child development. Stool microscopy, maternal-urinary iodine (as a proxy to assess children's iodine status), dietary history, child rearing practices (parenting) of mothers, perinatal history and socioeconomic conditions will be assessed at the beginning and children's language development at the end. Depending on availability of funds serum TSH will also be measured in children to exclude iodine deficiency. We will also measure mothers' nutritional and mental status to assess its relationship with children's development. The treatment effect will be examined by intention to treat analysis using multiple regression of the outcome variables controlling for initial measures and multilevel analysis will be conducted to control for differences at village level. The findings of this project will have implications both for international and national policies on early childhood development programs for IDA children.

NCT ID: NCT00658489 Completed - Iron Deficiency Clinical Trials

Implementation and Evaluation of Bright Futures Curriculum Within CORNET Continuity Practice

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of "Bright Futures" is to promote and improve infant, child, and adolescent health within the context of family and community. CORNET (COntinuity Research NETwork of the Ambulatory Pediatric Association) is a national practice-based research network of resident continuity practices, whose mission is to establish a self-sustaining collaborative research network among pediatric continuing clinic clinicians who will produce quality research in primary care, health care delivery, and education.